Unveiling the Therapeutic Potential of Nirmatrelvir–Ritonavir (NMV/r) in Real-World COVID-19 Data: A Call for Further Research and Evaluation
Saved in:
| Main Authors: | Sora Yasri, Viroj Wiwanitkit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-10-01
|
| Series: | Dr. Sulaiman Al Habib Medical Journal |
| Online Access: | https://journals.lww.com/10.4103/DSHMJ.DSHMJ_68_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world effectiveness of simnotrelvir-ritonavir versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 during the omicron wave in China: a retrospective cohort study
by: Chuntao Li, et al.
Published: (2025-07-01) -
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19
by: Franco Wing Tak Cheng, et al.
Published: (2024-05-01) -
MEN1-related hyperparathyroidism: Response to cinacalcet and calcium-sensing receptor gene variant Arg990Gly
by: Sora Yasri, et al.
Published: (2019-01-01) -
Expected Usefulness of Fourth Dose of COVID-19 Vaccine for Patients with Underlying Solid Tumor who Previously Received the Primary Heterologous COVID-19 Vaccine
by: Sora Yasri, et al.
Published: (2024-08-01) -
Effectiveness and safety of azvudine versus nirmatrelvir/ritonavir in hospitalized patients with COVID-19
by: Jin Yang, et al.
Published: (2025-05-01)